Solid Biosciences Inc.SLDBNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P8
Near historical low
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -60.00% |
| Q3 2025 | 10.53% |
| Q2 2025 | -17.46% |
| Q1 2025 | -7.44% |
| Q4 2024 | -25.04% |
| Q3 2024 | -10.44% |
| Q2 2024 | 14.79% |
| Q1 2024 | -20.98% |
| Q4 2023 | -16.35% |
| Q3 2023 | 34.84% |
| Q2 2023 | 1.89% |
| Q1 2023 | 18.81% |
| Q4 2022 | -68.78% |
| Q3 2022 | -28.66% |
| Q2 2022 | 41.60% |
| Q1 2022 | -30.26% |
| Q4 2021 | -13.30% |
| Q3 2021 | -7.74% |
| Q2 2021 | 19.97% |
| Q1 2021 | -1734.74% |
| Q4 2020 | 108.40% |
| Q3 2020 | -19.10% |
| Q2 2020 | 55.36% |
| Q1 2020 | -37.79% |
| Q4 2019 | -10.42% |
| Q3 2019 | 26.84% |
| Q2 2019 | -1.44% |
| Q1 2019 | -21.13% |
| Q4 2018 | -39.99% |
| Q3 2018 | 6.37% |
| Q2 2018 | 4.90% |
| Q1 2018 | -22.82% |
| Q4 2017 | -48.13% |
| Q3 2017 | 1.75% |
| Q2 2017 | 5.78% |
| Q1 2017 | -82.92% |
| Q4 2016 | 0.00% |
| Q1 2016 | 0.00% |